GNLY and COVID-19: Conversely, cytotoxic GNLY-expressing effector cell proportions and mature NK cells (NK_CD16hi) increased in Non-COVID-19, Post-COVID-19 and MIS-C but not in Post-Vaccination (Fig. 3b).